Biblio Discovery — Demo Discovery Service

26 results for "Elliot B. Tapper"

Showing 1–20 · 2.37 seconds · RSS

  1. Journal Article Full text

    Diagnosis and Management of Cirrhosis and Its Complications

    Elliot B. Tapper; Neehar D. Parikh

    JAMA · 2023 · English · OpenAlex

    Importance: Cirrhosis affects approximately 2.2 million adults in the US. From 2010 to 2021, the annual age-adjusted mortality of cirrhosis increased from 14.9 per 100 000 to 21.9 per 100 000 people. Observations: The most common causes of cirrhosis in the US, which can overlap, include alcohol use…

  2. Journal Article

    FIB-4 and APRI for cirrhosis detection in a privately insured national cohort

    Neehar D. Parikh; Manaav Mehta; Elliot B. Tapper

    JHEP Reports, Vol. 6 No. 1 · 2024 · English · DOAJ Scopus

    Background and Aims: Non-invasive laboratory-based fibrosis indices have been proposed as a tool for population-based screening for advanced fibrosis. We aimed to examine the performance of fibrosis indices at the time of and prior to cirrhosis diagnosis. Methods: We included adult patients with…

  3. Journal Article

    The need for antibiotic stewardship and treatment standardization in the care of cirrhotic patients with spontaneous bacterial peritonitis – a retrospective cohort study examining the effect of ceftriaxone dosing [v2; ref status: indexed, http://f1000r.es/3se]

    Laura Mazer; Elliot B. Tapper; Gail Piatkowski et al.

    F1000Research, Vol. 3 · 2014 · English · DOAJ Scopus

    Background: Spontaneous bacterial peritonitis (SBP) is a common, often fatal affliction for cirrhotic patients. Despite all clinical trials of ceftriaxone for SBP using 2g daily, it is often given at 1g daily. Aim: We evaluated survival after SBP as a function of ceftriaxone dosage. Methods: A…

  4. Journal Article Full text

    Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score

    Elliot B. Tapper; M. G. Myriam Hunink; Nezam H. Afdhal et al.

    PLOS ONE, Vol. 11 No. 2 · 2016 · English · PLOS Scopus

    Background: The complications of Nonalcoholic Fatty Liver Disease (NAFLD) are dependent on the presence of advanced fibrosis. Given the high prevalence of NAFLD in the US, the optimal evaluation of NAFLD likely involves triage by a primary care physician (PCP) with advanced disease managed by…

    Also available at: DOAJ

  5. Journal Article

    How Do Patients With Cirrhosis and Their Caregivers Learn About and Manage Their Health? A Review and Qualitative Study

    Zachary M. Saleh; Patricia P. Bloom; Katie Grzyb et al.

    Hepatology Communications, Vol. 5 No. 2 · 2021 · English · DOAJ Scopus

    The complexity of cirrhosis requires patients and their caregivers to be well educated to improve outcomes. Data are lacking regarding how to best educate patients and their caregivers in the setting of cirrhosis. Our aim is to understand (both through existing literature and by asking patients and…

  6. Journal Article

    Deprescribing zolpidem reduces falls and fractures in patients with cirrhosis

    Elliot B. Tapper; Zhe Zhao; G. Scott Winder et al.

    JHEP Reports, Vol. 4 No. 6 · 2022 · English · DOAJ Scopus

    Background & Aims: Benzodiazepines are associated with an increased risk of harm in patients with cirrhosis. However, stopping benzodiazepines must be done with care to avoid withdrawal or other unintended consequences. The impact of deprescribing on patients with cirrhosis is unknown. Methods: We…

  7. Journal Article

    Safety and effectiveness of phenobarbital vs. benzodiazepines for severe alcohol withdrawal in alcohol-associated liver disease in the ICU

    Rajalakshmi Govalan; Shengchen Hao; Michael T. Kenes et al.

    JHEP Reports, Vol. 8 No. 4 · 2026 · English · DOAJ Scopus

    Background & Aims: Severe alcohol withdrawal syndrome (SAWS) in patients with alcohol-associated liver disease (ALD) presents management challenges due to altered drug metabolism and increased toxicity. While benzodiazepines remain standard therapy, concerns about drug shortages, over-sedation…

  8. Journal Article

    The emotional burden of caregiving for patients with cirrhosis

    Zachary M. Saleh; Najat E. Salim; Samantha Nikirk et al.

    Hepatology Communications, Vol. 6 No. 10 · 2022 · English · DOAJ Scopus

    Abstract Caregivers for patients with cirrhosis face immense physical and psychological strain that negatively impact quality of life and ability to care for oneself. The aim is to explore the caregiver experience for patients with cirrhosis, identify prominent stressors, and understand the…

  9. Journal Article Full text

    Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases

    Jennifer C. Lai; Puneeta Tandon; William E. Bernal et al.

    Hepatology · 2021 · English · OpenAlex Scopus

    Supported by the American Association for the Study of Liver Diseases. Dr. Lai is partially supported by R01 AG059183 and R21 AG067554. Srinivasan Dasarathy is partially supported by NIH RO1 GM119174; RO1 DK113196; P50 AA024333; RO1 AA021890; 3U01AA026976 ‐ 03S1; UO1 AA 026976; R56HL141744;UO1…

  10. Journal Article

    Predictors of positive endoscopic findings in hospitalized patients with occult gastrointestinal bleeding

    Neil Sengupta; Elliot B. Tapper; Vilas R. Patwardhan et al.

    Gastroenterology Insights, Vol. 6 No. 1 · 2015 · English · DOAJ

    Anemia with occult gastrointestinal bleeding (OGIB) is a common reason for inpatient gastroenterology consultation and endoscopy. However, the utility of inpatient endoscopy in this setting is unclear. The aim of this paper is to determine variables that predict positive endoscopic examinations for…

  11. Journal Article

    Comprehensive Health‐State Utilities in Contemporary Patients With Cirrhosis

    Chelsey Foster; Jad Baki; Samantha Nikirk et al.

    Hepatology Communications, Vol. 4 No. 6 · 2020 · English · DOAJ Scopus

    Cost‐effectiveness analysis depends on generalizable health‐state utilities. Unfortunately, the available utilities for cirrhosis are dated, may not reflect contemporary patients, and do not capture the impact of cirrhosis symptoms. We aimed to determine health‐state utilities for cirrhosis, using…

  12. Journal Article

    Incidence of and Risk Factors for Hepatic Encephalopathy in a Population‐Based Cohort of Americans With Cirrhosis

    Elliot B. Tapper; James B. Henderson; Neehar D. Parikh et al.

    Hepatology Communications, Vol. 3 No. 11 · 2019 · English · DOAJ Scopus

    Hepatic encephalopathy (HE) is a devastating complication of cirrhosis. Data are limited regarding the incidence of and risk factors for HE among contemporary patients in the context of the shifting epidemiology of cirrhosis. We examined a 20% random sample of U.S. Medicare enrollees with cirrhosis…

  13. Journal Article

    The Burden of Nonalcoholic Steatohepatitis: A Systematic Review of Epidemiology Studies

    Elliot B. Tapper; Charlotte Fleming; Adriana Rendon et al.

    Gastro Hep Advances, Vol. 1 No. 6 · 2022 · English · DOAJ Scopus

    Background and Aims: Nonalcoholic steatohepatitis (NASH) is associated with increased mortality and risk of complications but is often asymptomatic and under-recognized. A systematic review of NASH epidemiology was conducted to provide information on the burden of NASH and highlight important…

  14. Journal Article

    Burden of metabolic dysfunction-associated steatohepatitis, with and without metabolic syndrome, obesity, or diabetes

    Elliot B. Tapper; Taylor Ryan; Dave Lewandowski et al.

    BMC Gastroenterology, Vol. 26 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Metabolic dysfunction-associated steatohepatitis (MASH) is commonly comorbid with metabolic syndrome; however, MASH can occur in the absence of metabolic syndrome. This retrospective cohort study evaluated the patient characteristics, healthcare utilization, and healthcare costs…

  15. Journal Article

    Body composition predicts mortality and decompensation in compensated cirrhosis patients: A prospective cohort study

    Elliot B. Tapper; Peng Zhang; Rohan Garg et al.

    JHEP Reports, Vol. 2 No. 1 · 2020 · English · DOAJ Scopus

    Background & Aims: Body composition, particularly sarcopenia, is associated with mortality in patients with decompensated cirrhosis undergoing transplant evaluation. Similar data are limited for non-transplant eligible or compensated patients. Methods: A total of 274 patients with cirrhosis were…

  16. Journal Article

    Cardiovascular disease in patients with metabolic dysfunction-associated steatohepatitis compared with metabolic dysfunction-associated steatotic liver disease and other liver diseases: A systematic review

    Arun J. Sanyal; Mansoor Husain; Crystel Diab et al.

    American Heart Journal Plus, Vol. 41 · 2024 · English · DOAJ Scopus

    The burden of cardiovascular disease (CVD) in patients with metabolic dysfunction-associated steatohepatitis (MASH) is poorly characterized, particularly vs other liver diseases including metabolic dysfunction-associated steatotic liver disease (MASLD). To identify available evidence, Embase…